Advances in molecular diagnostic tests for community-acquired pneumonia

Catia Cilloniz, Yuliya Poliakova, Juan C. Hurtado

Research output: Contribution to journalReview articlepeer-review


The use of a timely and appropriate antibiotic therapy, which requires early and accurate microorganisms’ detection in pneumonia. Currently, the identification of microorganisms in pneumonia is limited by the low sensitivity and long response time of standard culture-based diagnostic tools. For this reason, treatment in pneumonia is empirical. An inadequate empirical treatment is related to poor outcomes in patients with pneumonia. The microbiological diagnosis is key to improve the outcomes in patient with pneumonia. Over the past years there was a significant advance in the molecular diagnosis of infectious diseases including pneumonia. Also the impact of the COVID-19 pandemic has impacted the development and application of these new molecular techniques. This review summarizes the advances in molecular diagnosis of community-acquired pneumonia.

Original languageAmerican English
Pages (from-to)42-49
Number of pages8
JournalMinerva Respiratory Medicine
Issue number1
StateIndexed - Mar 2023

Bibliographical note

Publisher Copyright:


  • Community-acquired infections
  • Molecular diagnostic techniques
  • Pneumonia


Dive into the research topics of 'Advances in molecular diagnostic tests for community-acquired pneumonia'. Together they form a unique fingerprint.

Cite this